SAN DIEGO—Resmed announced it has received U.S. Food and Drug Administration (FDA) clearance for Personalized Therapy Comfort Settings (PTCS), to be marketed as Smart Comfort.
CPAP therapy
Largest ever meta-analysis on the long-term benefits of CPAP therapy found that in people with sleep apnea, CPAP therapy lowered the overall chance of dying
SAN DIEGO—Resmed, a global provider in health technology focused on sleep, breathing and care delivered in the home, announced the publication of a landmark meta-analysis in
A ResMed retrospective descriptive study of myAir usage data demonstrated a connection between continuous positive airway pressure (CPAP) device usage, digital health applications and high compliance. According to the study of 2,343 de-identified patient records, researchers found 83.9 percent of new CPAP users who received standard care and used the ResMed myAir application achieved Medicare adherence in the first 90 days of their treatment.
Though providers face significant odds, out-of-the-box thinking could stabilize—and potentially increase—revenue
Alabama oxygen provider relies on relationships to spur his company's growth
Reality TV contestants champion importance of sleep.